Reset Map2 Results
105 Maple Avenue Goffstown, NH, 03045 United StatesAt BioAI, we are accelerating biomarker discovery and development using novel machine learning technology -- identify and understand novel drug targets, advance diagnostic accuracy, and improve drug efficacy with BioAI's custom biomarker services. We also offer biobanking services -- gain access to archival and prospective sample collections for FFPE, PBMC, Plasma, and samples for rare indications. BioAI service offerings include: Biospecimen Procurement --Gain access to human biospecimen samples for rare indications or custom collections for your specific research needs, oncology and beyond AI Biomarker Services -- Predictive AI models for known genetic mutations or novel biomarkers: BioAI has a strong experience and track record in developing H&E-based AI models for known genetic mutations in various cancer indications. A major use case is applying H&E-based digital biomarkers to screen or pre-screen patient eligibility for clinical trials in order to expand the access to patients suited and to significantly reduce overall testing costs. Special Capabilities: -Developing AI models for broad bandwidth of cancer indications, such as lung, breast, melanoma, and more -Developing AI models to predict the status of genetic mutations, e.g. RET, EGFR, ROS1, ALK, NTRK, BRAF -Different measures and novel approach working towards high generalizability of AI algorithms -High performance of AI models; with sensitivity and specificity modeled according to the specific needs -Determination of pathological and molecular factors that might play a role in patient response to therapy and drug resistance -Novel biomarker development in the form of AI models for outcome prediction: predict treatment outcomes, disease resistance factors, adverse events, and long-term patient responses -Identification of patient subgroups likely to respond to specific therapies, enabling more targeted treatment strategies Leverage our AI Platform for Clinical Research --Our technology integrates complex data sets from translational studies and clinical trials and develops machine learning models on multi-omic data that can help predict patient response to therapy & drug resistance
1662 Elm St Manchester, NH, 03101 United StatesAt BioAI, we are accelerating biomarker discovery and development using novel machine learning technology -- identify and understand novel drug targets, advance diagnostic accuracy, and improve drug efficacy with BioAI's custom biomarker services. We also offer biobanking services -- gain access to archival and prospective sample collections for FFPE, PBMC, Plasma, and samples for rare indications. BioAI service offerings include: Biospecimen Procurement --Gain access to human biospecimen samples for rare indications or custom collections for your specific research needs, oncology and beyond AI Biomarker Services -- Predictive AI models for known genetic mutations or novel biomarkers: BioAI has a strong experience and track record in developing H&E-based AI models for known genetic mutations in various cancer indications. A major use case is applying H&E-based digital biomarkers to screen or pre-screen patient eligibility for clinical trials in order to expand the access to patients suited and to significantly reduce overall testing costs. Special Capabilities: -Developing AI models for broad bandwidth of cancer indications, such as lung, breast, melanoma, and more -Developing AI models to predict the status of genetic mutations, e.g. RET, EGFR, ROS1, ALK, NTRK, BRAF -Different measures and novel approach working towards high generalizability of AI algorithms -High performance of AI models; with sensitivity and specificity modeled according to the specific needs -Determination of pathological and molecular factors that might play a role in patient response to therapy and drug resistance -Novel biomarker development in the form of AI models for outcome prediction: predict treatment outcomes, disease resistance factors, adverse events, and long-term patient responses -Identification of patient subgroups likely to respond to specific therapies, enabling more targeted treatment strategies Leverage our AI Platform for Clinical Research --Our technology integrates complex data sets from translational studies and clinical trials and develops machine learning models on multi-omic data that can help predict patient response to therapy & drug resistance
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.